Form 4: Procter & Gamble Executive Gary Coombe Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Gary Coombe, a Procter & Gamble executive, executed multiple transactions involving company stock, including the acquisition and sale of shares and the vesting of restricted stock units.

Summary

  • Gary Coombe, CEO of Grooming at Procter & Gamble, reported several transactions involving the company's stock.
  • On November 27, 2024, Coombe acquired 47,847 shares of common stock at $91.07 per share through the exercise of stock options.
  • On the same day, Coombe sold 47,847 shares of common stock at a weighted average price of $179.8375 per share, with prices ranging from $179.60 to $180.04.
  • Coombe also holds 466.1497 shares indirectly through a retirement plan trustee and 1,295.35 shares indirectly through an international stock ownership plan and pension plan.
  • Additionally, 46.1626 restricted stock units (RSUs) vested on November 15, 2024, which will be delivered in shares upon retirement unless deferred.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions, with no inherent positive or negative sentiment. It is a routine filing.

Positives

  • The exercise of stock options at $91.07 and subsequent sale at a higher price of $179.8375 indicates a profitable transaction for the executive.
  • The vesting of restricted stock units adds to the executive's overall compensation and stake in the company.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies. It provides transparency into the trading activities of insiders.

Comparison to Industry Standards

  • Executive stock transactions are a common occurrence in publicly traded companies like Procter & Gamble.
  • The reporting of these transactions via SEC Form 4 is a standard regulatory requirement.
  • The specific details of the transactions, such as the exercise price and sale price, are typical for stock option exercises and sales by executives.
  • Companies like Unilever, Colgate-Palmolive, and Kimberly-Clark also have executives who regularly report similar transactions.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders, as they are routine executive stock trades.
  • The disclosure provides transparency to shareholders regarding executive compensation and trading activity.

Key Dates

DateDescription
02/28/2020Date of grant for stock options that were exercised on 11/27/2024
11/15/2024Date restricted stock units vested.
11/27/2024Date of stock option exercise and sale of shares.
12/02/2024Date of signature on the SEC Form 4 filing.
02/26/2027Expiration date of stock options exercised on 11/27/2024

Keywords

Procter & Gamble, stock transactions, insider trading, stock options, restricted stock units, executive compensation, SEC Form 4, Gary Coombe

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.